Related Experiment Video
Updated: Jun 5, 2026
16:01
Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
Mast cells and metabolic syndrome
1Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Biochimica Et Biophysica Acta
|December 28, 2010
Summary
Mast cells, key immune responders, are implicated in allergic and inflammatory diseases. Emerging evidence links mast cell activity to metabolic disorders like type 2 diabetes and obesity.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Mast cells are crucial immune cells involved in allergic reactions and inflammatory responses.
- They release mediators like histamine, cytokines, and proteases, contributing to both physiological and pathological processes.
- Mast cells are increasingly recognized for their role in inflammatory diseases, including cardiovascular complications and metabolic disorders.
Purpose of the Study:
- To explore the involvement of mast cells in the pathogenesis of metabolic diseases.
- To review the current understanding of mast cell contributions to insulin resistance and type 2 diabetes.
- To highlight the potential of mast cell modulation for treating obesity and diabetes.
Main Methods:
- Review of existing literature on mast cell function in inflammation and metabolic diseases.
- Analysis of data from animal models demonstrating mast cell participation in diet-induced obesity and diabetes.
- Examination of established mast cell pathobiology in cardiovascular diseases.
Main Results:
- Mast cells directly participate in the development of diet-induced obesity and diabetes in animal models.
- Their role in insulin resistance and type 2 diabetes is supported by recent observations.
- Mast cell pathobiology is well-established in cardiovascular diseases, with available inhibitor medications.
Conclusions:
- Mast cells are significant contributors to the pathogenesis of metabolic diseases, including obesity and type 2 diabetes.
- Understanding mast cell mechanisms in metabolic disorders is crucial for therapeutic development.
- Mast cell inhibitors show promise for treating these common chronic inflammatory conditions.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:38Inflammation
Overview
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...